Teva- Pharmaceutical Industries Net Tangible Assets

As of the most recent data (June 2026), TEVA shows a net tangible assets of $7.8B. That compares with $6.8B in the prior-year period — up 13.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TEVA's net tangible assets is now $7.8B (was $6.8B) — a 13.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Teva- Pharmaceutical Industries is outperforming or lagging.

Tracking TEVA's net tangible assets over time shows whether Teva- Pharmaceutical Industries is scaling, shrinking, or reshaping that part of the business. The current reading is $7.8B That compares with $6.8B in the prior-year period — up 13.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Teva- Pharmaceutical Industries's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $7.8B) with ownership activity and broader fundamentals.

Teva- Pharmaceutical Industries's net tangible assets is $7.8B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.